Trade Summary

4 days ago, Shefferman Jesse, serving as CEO and President at Protara Therapeutics, Inc. (TARA), sold 215,687 shares at $4.09 per share, for a total transaction value of $882,159.83. Following this transaction, Shefferman Jesse now holds 721,832 shares of TARA.

This sale represents a 23.01% decrease in Shefferman Jesse's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 4:10 PM ET, 2 days after the trade was made.

Protara Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.